InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Dale Stephen, Directeur Médical. Director active across 1 company, notably Kura Oncology, Inc.. Cumulatively, 4 filings have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €128k. History available since 26 January 2022. The latest transaction was filed on 29 January 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Dale Stephen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
4,400 股@ US$17.800556.4% 占其流量Common StockSEC:0000950170-24-009493:0
23,125 股0Common StockSEC:0001209191-23-011283:0
4,385 股@ US$13.890343.6% 占其流量Common StockSEC:0001209191-23-005744:0
36,900 股0Common StockSEC:0001209191-22-005367:0
4 条申报中的 4 条
About Dale Stephen
Stephen Dale is the Chief Medical Officer at Kura Oncology, Inc. He oversees the company's medical and clinical initiatives, contributing to innovation and the development of new treatments. His role is essential for the company's success.
